J.P. Morgan analyst David Adlington maintained a Sell rating on Carl Zeiss Meditec (0DHC – Research Report) today. The company’s shares closed ...

Hauck & Aufhaeuser analyst Alexander Galitsa maintained a Buy rating on Carl Zeiss Meditec (0DHC – Research Report) today and set a price ...

Carl Zeiss Meditec shows solid recovery signs, especially in China/US, with strong growth in equipment and consumables. Read ...

Carl Zeiss Meditec AG ( ETR:AFX ), is not the largest company out there, but it saw a significant share price rise ...

(Il Sole 24 Ore Radiocor) - Milano, 11 mar - Carl Zeiss Meditec shares were sharply higher in Frankfurt trade after Goldman Sachs raised its recommendation on the German medical technology group ...

Carl Zeiss Meditec reported a fall in net profit for the first quarter of fiscal 2025 despite a slight uptick in revenue, as it warned of a continuing challenging macroeconomic environment.

Investing.com -- Shares of Carl Zeiss Meditec AG (ETR:AFX) dropped 6% today after the company reported its first-quarter revenues, which showed a slight increase of 1.2% versus the Vara consensus ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Carl Zeiss Meditec AG (“Carl Zeiss”) is proud to honor EuroEyes International Eye Clinic Limited (“EuroEyes International” or the “Company”) for achieving the prestigious title of the most AT LISA® ...

Carl Zeiss Earnings: Soft Readout, Continued Market Challenges, and Dividend Cut Send Shares Down Narrow-moat Carl Zeiss Meditec reported soft fourth-quarter earnings that came in lower than our ...